It was a busy week at the bottom of the market, where companies go to dissolve, dilute, or sell their vital organs for the price of a used Honda Civic. We saw a masterclass in toxic financing, a bizarre fire sale, and a wave of liquidations reminding us that sometimes the best way to maximize shareholder value is just to turn off the lights and lock the door.
MV Oil Trust (MVO): The Well Runs Dry
MV Oil Trust hit its production thresholds, meaning the net profits interest that gave the trust a reason to exist is officially exhausted. The entity is now winding down operations and voluntarily delisting from the NYSE. This is the rare micro-cap dissolution that actually goes according to design. The well ran dry, the trust is over, and everybody goes home. On July 2, they announced their final cash distribution. The stock is lingering around $1.70 while investors wait to collect their last checks before the ticker disappears.
Lifecore Biomedical (LFCR): A $14 Million Math Problem
The preferred equity holders at Lifecore Biomedical want their money back. The company received redemption notices for 100% of its Series A Preferred Stock, totaling roughly $52.1 million. There is a glaring math problem here: Lifecore only has $38.1 million in total liquidity. They are legally obligated to settle this gap by late December, but doing so requires lender consent they do not yet have. If they miss the deadline, they get hit with a 1% monthly penalty interest rate. The stock is languishing around $5.30 as the market waits to see if they can scrape together the debt, equity, or strategic miracle required to plug a very immediate liquidity hole.
Alpha Modus Holdings (AMOD): Signing Away the Farm
Alpha Modus decided they needed $10 million and were willing to sign essentially anything to get it. They entered a secured financing agreement with Streeterville Capital that features all the classic hallmarks of a death spiral: heavy VWAP discounts, floor price triggers, and a first-priority lien on every asset and piece of IP the company owns. The CEO even subordinated his own debt to the new investor. If the stock drops below $0.81 for five consecutive days, a mandatory cash repayment is triggered. For now, the stock is somehow trading around $4.70, keeping the wolves at bay, but this is a loaded gun with a very light trigger.
Origin Materials (ORGN): Turning off the Lights
The end is here for Origin Materials. Following a special meeting on July 1, shareholders officially approved a total liquidation and dissolution of the company. Origin had already gutted its workforce by 59% in May after failing to secure capital or a buyout. Now, it is a pure salvage operation. They will sell off their PET cap technology and remaining assets, wind down operations, and distribute whatever couch-cushion change remains. They voluntarily delisted from the Nasdaq on July 2, and the stock is trading near $0.95. The going concern is gone.
Advanced Biomed (ADVB): The $23,000 Fire Sale
Advanced Biomed engaged in a bizarre transaction, dumping its Hong Kong subsidiary—and all the intellectual property inside it—for a nominal $23,000. Divesting your core technological engine for the price of a gently used Corolla is usually step one in abandoning the operating business entirely to become a shell. And that is exactly what happened. Since that filing, ADVB executed a 1-for-20 reverse split, pivoted into being an AI firm by acquiring a new business in May, and just sold off its Taiwan R&D arm in June for $490,000. The shell has been scrubbed clean and a new business has been shoved inside. The stock now trades near $5 post-split, completely decoupled from the legacy biomed assets they gave away for pennies.
What to Watch
The Lifecore liquidity crunch is the most urgent fundamental event on the board right now. Watch the filings to see if they price an emergency equity raise or secure an expensive debt bridge before the 180-day clock runs out. Meanwhile, Alpha Modus will be a live exercise in how fast a dilutive floor-price trigger can drag a stock down once the selling pressure starts. Until next week.